First Inter-state Heart Transplant in Navi Mumbai

Mumbai, October 14, 2017: Apollo Hospitals, Navi Mumbai, today created a "Green Corridor" for the transportation of "Donor Heart" retrieved from a 43 year old brain dead patient. The "Green Corridor" was created from Apollo Hospitals, CBD Belapur to Chhatrapati Shivaji Terminus (Domestic). A distance of 32 kms was covered in 40 minutes. Green Corridor Route: Apollo Hospitals, CBD Belapur, Palm Beach Road, Mumbai – Pune Highway, Vashi Toll Booth, Mankhurd Ghatkopar Link Road, SCLR, Western Express Road and the Airport Dr Prasad Mugalikar, Medical Director, Apollo Hospitals, Navi Mumbai, s

Unity 2017.2 Gives Artists and Designers the Power to Unleash Their Full Creativity in 2D, 3D and XR Starting Today

New visual tools and collaboration with Auto desk makes Unity 2017.2 the best creation engine for all artists, developers and creators   San Francisco, October 13, 2017: Unity Technologies ( https://unity3d.com/ ), creator of the world's most popular creation engine that reaches nearly 3 billion devices worldwide, announced today that Unity 2017.2 is now available to download from the Unity Store. Unity 2017.2 is the most powerful content creation tool set to-date, delivering an end-to-end solution for 2D games and XR creation, as well as optimized support for ARCore, ARKit, Windows Mix

Asian healthcare market is expected to grow over $2660 billion in 2020: The Economic Times Best Asian Healthcare Brands 2017 lauded Asian Healthcare brands that have positively impacted the community

Dubai, October 13, 2017: After the successful launch of the first edition of the Best Healthcare Brands in India in 2016, The Economic Times announced the Asian edition of the book in Dubai, UAE. It was at the recently concluded Economic Times India-UAE Strategic Conclave held at Westin Dubai that insightful discussions on the opportunities and challenges for Asian healthcare brands came to light. The Economic Times Best Asian Healthcare Brands 2017 was unveiled by H.E. Sheikh Nahyan bin Mubarak Al Nahyan, UAE’s Cabinet Member and Minister of Culture and Knowledge Development. The initiati

Market launch: new filling and closing machine AFG 5000 from Bosch

Compact and high-speed powder filling Output of up to 480 vials per minute Number of filling points can be individually selected Optimal use of work stations thanks to the new transport system New Delhi, October 08, 2017: Stuttgart / Crailsheim, Germany – As part of an exclusive machine presentation in Crailsheim from September 18 through 29, 2017, Bosch Packaging Technology introduced the latest addition to its AFG series. The filling and closing machine for pharmaceutical powders in glass vials offers manufacturers a wide range of options. “During development, our main focus was

Majority of women do not know early signs of breast cancer, finds global survey by Avon

Less than half (42%) are confident that they know what changes to their breast could be a sign of cancer A quarter (25%) think that a lump is the only sign of breast cancer that can be identified without medical equipment Avon India launched #PayAttention, an initiative educating women to take up a self-examination to detect early symptoms New Delhi, October 08, 2017: Only two in five people (42%) are confident about recognizing the changes to their breasts that could be a sign of cancer, according to a new survey of 19,000 respondents by Avon Products, Inc., the world's leadin

Philips appoints Daniel Mazon as Vice Chairman & Managing Director for India subcontinent

New Delhi, October 08, 2017: Philips India, today announced the appointment of Mr. Daniel Mazon as Vice Chairman & Managing Director for India subcontinent, effective from 3 rd October, 2017. In his new role, Daniel will be responsible for driving the overall growth for Philips businesses in India, while focusing on customers and operational excellence. Daniel takes over from Mr. V. Raja, Vice Chairman and Managing Director for Philips in India who retired on 30th September, 2017. Daniel is a seasoned leader with close to two decades of work experience in the healthcare industry. Daniel

Endress+Hauser appoints new COO

New Delhi, October 05, 2017: Endress+Hauser a Switzerland-based instrumentation and process automation company announces the appointment of a new Chief Operating Officer with effect from 1 October 2017. Kailash Desai has been promoted to this position and will take charge of the India business. In his stint with Endress + Hauser since 2003, he worked in various management roles focusing on marketing and sales, while also gaining experience in human resources and the projects business. Following an assessment of more than 100 applicants for the job (including both internal and external applican

CPhI Worldwide to support International Medical Corps UK with global charity partnership

Collaboration to help raise funds, awareness and engagement from pharma community for the charity's lifesaving work in crises across the globe Amsterdam, October 05, 2017 : CPhI Worldwide, organised by UBM, announces a new dedicated charity partnership with International Medical Corps UK. The collaboration will see UBM extensively promote International Medical Corps across the global pharma community, with a range of fundraising and customised sponsorship packages. International Medical Corps UK was selected in light of its vital work in delivering lifesaving healthcare and medicine on the f

Columbia Asia Hospital - Mysore to Introduce City’s First Advanced Cardiac Diagnosis in Real Time

ECG machines with Artificial Intelligence to be placed at multiple nursing homes for immediate expert cardiac opinion. Mysore, October 05, 2017 : Columbia Asia Hospital - Mysore, has announced a first of its kind initiative in the city - a complete technological solution to diagnose and interpret cardiovascular issues in real time. The technology works on an Artificial Intelligence (AI) platform handheld device that can provide preventive cardiac care to people who may not even be aware that they have heart issues. On the occasion of the World Heart Day Columbia Asia dedicates this to the

Scott Sports India launches their pedal assisted E-Bikes range for 2018 and their #BuildYourVision service to change the future of bicycling in the country

New Delhi, September 30, 2017: SCOTT Sports India, the Indian arm of the globally recognized multi sport company SCOTT Sports,launched their 2018 range in India this month. The main highlight is the launch of their pedal assisted E-Bikes range which is the first in the country. This move by SCOTT marks the beginning of a technological revolution in the field of bicycling in India. The second highlight is the launch of their #BuildYourVision service wherein you can personalize your road bike by choosing your own frame and components, thus creating a tailored product unlike anyone else’s. C

Hilleman Laboratories receives Indo-Swedish grant for developing - Oral Cholera Vaccine (OCV)

New Delhi, September 30, 2017: Hilleman Laboratories, a joint-venture partnership between MSD and Wellcome Trust, received a 6 million krona Indo – Swedish grant for the project ‘Improved, affordable single strain whole cell-B subunit oral cholera vaccine’. The proposed project, carried out by Hilleman Laboratories, is being jointly funded by the Department of Biotechnology (DBT), Government of India andVinnova,the Swedish Governmental Agency for Innovation Systems. The project will fuel further Research & Development of the Oral Cholera Vaccine (OCV) with knowledge exchange and t

Indian hair champion prepares for World Skills International

New Delhi, September 30, 2017: The young, 19 years old A. Karan is burning the midnight oil, untiringly practicing his skill for over 16 hours every day. He starts at 9 am and practices haircuts and hair styles through the day till 7 pm. He takes a break for a couple of hours and whips out his scissors, combs and hairdryer and starts snipping, styling, setting hair way past midnight. His trainers jokingly say that he must be practicing styles even in his dreams. For Karan hairdressing is a passion and it is only apt that he is representing India in hairdressing at the World Skills Competition

This World Heart Day, Embrace Yoga, the Holistic Workout for Your Body & Mind by Akshar, Founder, Director, Akshar Yoga

New Delhi, September 29, 2017: Yoga is referred to as one of the most ancient healing techniques, originated in ancient India. Yoga has been a part of our lifestyle. Our sages practiced it to enhance inner tranquility and spiritual insights. Yoga is performed slowly, stretching the body into various poses, focusing on the breath and meditation. A healthy heart could reflect in your healthy being. A healthy trend of the day is the growing consciousness in the current generation on health and healthy living. A greater number of youngsters are willing to try different sorts of workouts to maintai

Cornitos launches ‘9 Star Dip O' Treat’ in New, festive packaging

New Delhi, September 29, 2017: This season, Cornitos, the flagship brand of Greendot Health Foods Pvt Ltd brings the ‘9 Star’ gift pack in all new packaging for its consumers. The newly designed Gift box contains assorted nachos flavors and dips, packed individually in an attractive and classy packaging. Perfect for the gifting season ahead, 9 Star Dip O’ Treat makes a nice, healthy treat for your loved ones. As the name suggests Cornitos ‘9 Star Dip O’ Treat’ will add 9 stars to your celebrations. Gift box contains nine packs of 30g nacho crisps in new, vibrant packaging along wi

SRL Analysis reveals Women all over India equally at Risk of Heart Diseases

Data Analytics Report based on more than 3.3 Million samples received from women for Lipid profile testing 41% of samples tested showed abnormal lipid levels across India New Delhi, September 29, 2017 : Cardiovascular diseases (CVDs) are the number one cause of death globally and are the leading cause of death in India also. The most common tests that are done to check the risk of CVD are the lipid tests. The general knowledge is that CVD is more prevalent in men than in women and South Asian men encountering a heart attack are at least 5 years younger than women on an average. A recen

Upcoming Events
Automation Expo 2018 - 13th International Exhibition & Conference

Automation Expo 2018 - 13th International Exh... After delivering a grand and s

Vascular Biology 2017

Vascular Biology 2017... The committee of International

Metabolomics Conference 2017

Metabolomics Conference 2017... “9th International Conferen

Nucleic Acids 2017

Nucleic Acids 2017... We are pleased to invite the c

Biosimilars Asia 2017

Biosimilars Asia 2017... 8th Asian Biosimilars Congre

Pharmacognosy 2017

Pharmacognosy 2017... Conference Series LLC invites

Heart Diseases 2017

Heart Diseases 2017... The Annual Conference on Heart

19th Euro Cancer Science and Therapy Congress

19th Euro Cancer Science and Therapy Congress... Conference Series LLC extends

Structural Biology 2017

Structural Biology 2017... Conference Series LLC welcome

Clinical Research 2017

Clinical Research 2017... Clinical Research 2017 Confere

Pharmaceutical and Biomedical Engineering 2017

Pharmaceutical and Biomedical Engineering 201... ConferenceSeries Ltd is a reno

International Conference on Enzymology 2017

International Conference on Enzymology 2017... INTERNATIONAL CONFERENCE ON EN

5th International Conference and Exhibition on Pharmacology & Ethnopharmacology

5th International Conference and Exhibition o... Conference Series LLC invites

Cardiac Pharmacology 2017

Cardiac Pharmacology 2017... Conference Series LLC is a ren

  • Cannot retrive forecast data in module "mod_sp_weather".


Mumbai, Baltimore, October 18, 2012:   – Pharma major, ...
Our claims ratio has Being vigilant against overcharging by hosp
HUL to enter into agHUL announced today that it will enter into a
Max Healthcare's GroNoida, Uttar Pradesh, India, Friday, December
Nobody is too young Life is in motion and when that motion gets
Ranbaxy gets approvaNew Delhi January 9, 2014: Ranbaxy Laboratori

Press Release

January 2, 2013: Glenmark Generics Inc, USA, the United Stat...
ClearPath RevolutionNew Delhi February 18, 2014: ClearPath Ortho
Homeopathy – An ef Global summit shows path-breaking researc
Shri J P Nadda at AA“Promotive and preventive health to empower
Trust Launches KarnaBangalore, October 10, 2013: Trust Chemists a
Premia Group Enters The Indian Healthcare sector is soon going


Favorable Performance Over 2011 Periods Continues Hawthorne...
New Assistance App fNew Delhi March 11,2014: The world’s leadin
An Initiative by HCGIndia - Emerging Leaders in Molecular Imaging
Centre de that any eAbu Dhabi - in 3 February 2014 :-  Said cent
Drugmakers Should Di January 4, 2014: Doctors and researchers sh
International medicaNew Delhi, March 13,2014: More than 450 exhib


Bangalore, June 26, 2014 - Ms Kiran Mazumdar-Shaw, Chairper...
AstraZeneca ExcellenAt AstraZeneca, we recognize that advances in
Cambridge varsity hoMUMBAI, July 05, 2014 : Yusuf Khwaja Hamied,
Advanced Enzymes winAdvanced Enzyme Technologies Ltd. recently re
India Set to Crown t The rise of profession goes manifold says re
Fortis Healthcare aw1107 errors proactively identified and rectif
Category: Company News

New Delhi, July 05, 2014 - Arecent McKinsey report states that Indian pharmaceutical market can reach USD 55 billion by 2020, and the market has also the potential to touch USD 70 billion, but it comes with a rider. To achieve this target, the industry should putconcerted efforts in the five key emerging opportunities namely, patented products, consumer healthcare drugs, biologics, vaccines, and the public health market.The same report also cautions that pricing control and economic slowdown may lead to a downturn in the market, to USD 35 billion.

While the external factors get difficult to control, the pharmaceutical companies need to strengthen the internal operational capabilities, in order to grow profitably. The rising industry complexity is a factor thatcompels the industry players to boost collaboration among the stakeholders and strive to sustain the performance. The major challenges that are impacting the business prospects for Indian pharmaceutical companies include quality of drugs, quality of clinical trials, and patent issues.Recently, some Indian pharmaceutical companies have been penalized in the USA for flouting FDA norms.

Cost leadership is a major differentiator for market competitiveness. Large pharmaceutical companies are normally adopting various strategic business initiatives such as ERP, Six Sigma, Lean, TQM, TPM, and contemporary management accounting techniques to optimize productivity and cost of the product. As business complexity in pharmaceutical sector is a given, it is an imperative for the pharmaceutical companies to adopt technology solutions to increase the operational excellence. With advanced technology solutions, the pharmaceutical companies can improve the visibility of data across the business processes and can take faster business decisions.

Inherent Challenges in Life Sciences Industry

Missing Operational Excellence

Pharmaceutical companies should strive foroperational excellence to thwart market competition. To achieve operational excellence, the pharmaceutical companies should focus on better quality, industry compliance, increased productivity, higher throughput, low utility cost, and less waste.However, the small and medium enterprises (SMEs) are reluctant to invest in technology. Lower technology investment restricts the operational efficiency of the company and increases the operational cost.

Lack of Data-driven Decisions

Since pharmaceutical industry is highly scientific process oriented, it is necessary for the companies to explore data-driven decision making. According to a Thompson Reuters report, 26.5% IT leaders catering to the IT needs of pharmaceutical industry predict that “big data” will play a major role in the decision making process.There is an urgent need to exploit“big data”to derive useful insights for better planning and decision-making. Unfortunately, the Indianpharmaceutical industry is slow to catch up with this technological trend.

Inefficient Supply Chain

Supply chain is the backbone of pharmaceutical industry. From drug discovery to clinical trials, to manufacturing, to distribution, each segment requires a robust supply chain management process to increase productivity and operational inefficiency. According to a report, an efficient supply chain management can reduce inventory holding by 25%-60% and improve the order fulfillment cycle time by 30%-50%. But the inability of developing an efficient supply chain costs the companies heavily. For example, poor inventory planning can cost a pharmaceutical company 10%-18% of net revenues.

Stringent Regulatory Control

There is an increasing need for compliance with regulatory norms of different countries and international agencies such as FDAand WHO. If a company wishes to market the products in the US region, an approval from FDA is mandatory. The clinical trial process also attracts major attention from the FDA regarding safety, efficacy, capacity, and purity of the drug. The pharmaceutical companies are also subject to various state and federal laws regarding production environment, safety, and environment protection.

Poor Drug Quality

Quality is a major issue with pharmaceutical manufacturers. In 2013, a major Indian pharmaceutical company was penalized in the US for flouting the FDA quality norms.There are many instances when Indian regulators collude with local manufacturers to approve the products. This allows smaller companies to manufacture sub-standard drugs and market it in the developing countries.The sub-standard drugs available at lower price pose a threat to the quality drugs marketed by leading pharmaceutical companies.

Leveraging the Technology to Optimize Growth Opportunities

What’s required for Indian life sciences companies today to mitigate the daunting challenges is, to adopt technology solutions. For example, Tectura® Life Sciences solution, built on Microsoft Dynamics, covers all business areas: from purchasing, sales, production, financial accounting, quality control, vendor rating, raw material data management, laboratory systems, resource management, warehouse management, and logistics, to marketing and distribution. Many leading life sciences companies of India have leveraged this solution to improve their operational efficiency.Life sciences companies require customized solution to address their challenges.For example, order management, formulation,active ingredients administration, inventory management, lot tracing, sequence planning, quality management, supply chain management, and production planning are the key areas to be integrated.

Bringing in Manufacturing Excellence

Companies need a solution having greater flexibility, easy integration, and extensive features to support the business operations. Components like manufacturing specification provide data to core ERP solution through an interface, which is version controlled and user authenticated. Similarly, formulae,BOMs, and recipes are critical data structures that life sciences companies adhere to strictly. Tectura Life Sciences offers extensive functionalities to configure manufacturing specifications, recipes, formula’s bills of materials (BOMs), and work plans. The manufacturing specifications can be integrated with Microsoft Dynamics solution. It helps compiling all necessary work instructions basis the production plan. Being version controlled and protected by password, this module ensures that data security is maintained.

Conforming to Regulatory Compliances

As life sciences companies need to meet the FDA/GMP/WHO compliances, there is an urgent requirement for the companies to look for a comprehensive solution that can help reduce the risk of non-compliance along with complete visibility into the quality of products. Tectura Life Sciences solution allows companies to ensure adhering to FDA regulations, complying with standard operating procedures, and validating the industry checklists.This solution is compliant with GMP requirements, and maintains audit trails and signature records for both manual and automated transactions to satisfy 21 CFR Part 11.

Ensuring Better Quality of Products

In life sciences industry, quality management acts as an ethical guide to deliver the product as promised to customers. The industry has a mandate to comply with a number of regulatory compliances, which again largely address to the quality of the product. Tectura Quality Management solution offers a wide range of measures such as test plans, process tests, test orders, test accuracy control, skip-lot function, and vendor rating to thwart the challenges. The solution also provides components to integrate client-defined measures to abide by the quality policies of the company. Companies can easily integrate all test areas with procedural documents to ensure easy validation.

Faster Product Recall

Lot tracing is a critical component for life sciences operational process. For instance, during FDA audits if any product fails to meet the standards, then the company should recall the product immediately. Tectura's Life Sciences solution enables complete lot and serial traceability with forward and backward tracking capability across the production chain. This feature improves the response time for product recall and ensures peace of mind for the manufacturers.

Efficient Production Planning

During production planning and control stage, life sciences companies need planning functionalities that allow optimal resource utilization. Companies require integrated sequence planning to configure planning parameters, schedules, resource availability, and sequencing. Mostly, at production floor short-term changes are expected due to machine failures and unplanned customer orders. The production manager should ensure that resource utilization is optimized and transparency is built into the system. With advance sequence planning module of Tectura Life Sciences, companies can even handle ad hoc requirements more efficiently without disturbing the scheduled jobs. During scheduling and sequence optimization, the production floor manager can verify inventory to check whether the required materials are available in the stock and right measures are predefined in the system.

Managing Cost Optimally

As life sciences companies use myriads of raw materials to compose a complex molecule, calculating the costing of individual ingredients is necessary. While many ERP solutions have inherent issues in calculating the cost of a product, Tectura Life Sciences solution helps calculate the production cost basis the raw material price and the amount of portion used. Various fixed and variable costs are defined to estimate the final cost of the finished product. Using this solution, companies can define the size of lots and relationship between quantity and unit cost.


As the Indian life sciences industry is faces global competition, itiscrucial for the business owners and decision makers of the company to rely on comprehensive business solutions to mitigate the daunting challenges. Many leading pharmaceutical companies have trusted innovative business solutions like Tectura Life Sciencessolution that integrates all business processes, including production and planning, quality, supply chain, sales and marketing, and finance and accounting. It allows companies to bring in operational excellence,conform to quality and regulatory compliance,and increase profitability.

About the Author

Mr. Chetan Pathak, Corporate Operations Director, Tectura India

Managing at the helm of Tectura India, Chetan exemplifies Tectura’s commitment to delivering exceptional and sustained value to the clients. Chetan joined Tectura India as Corporate Operations Director in April 2009. With an extensive and diverse experience of over 26 years in the areas of technology and consulting business, Chetan spearheads Tectura’s strategy for operations in India, Nepal, Bangladesh, Sri Lanka, Maldives, Mauritius, and New Caledonia. Chetan is Tectura India’s primary decision- and policy-maker, setting the tone for company’s values, ethics, and culture.

In this capacity, Chetan provides complete leadership on strategic and operational issues. A proven leader with deep expertise in executing on strategic global, regional, and local initiatives and goals, Chetan manages growth of Tectura India’s business, profitability, and customer satisfaction. With a passion for mentoring and coaching, Chetan builds up the path for enterprise leadership team. At Tectura India, he drives three revenue streams – Local Business, Direct Offshoring, and Inter-company Business. Chetan leads relationship management with Microsoft and various channel partners. His focus for business excellence has helped Tectura India achieve many awards from Microsoft locally and globally.

Prior to joining Tectura India, Chetan was the Vice President – India Operations, Ramco Systems. At Ramco Systems, he was responsible for managing the Enterprise Solutions business, Enterprise Process Solutions business, SaaS business, and BPO. Before joining Ramco Systems, Chetan also worked with leading technology organizations such as Tata Unisys and IDM Ltd. Chetan holds a BE degree in Mechanical Engineering and MBA in Marketing Management from Gujrat University. CCI Newswire

Email address:



Read more


Exclusive on Pharma Times

New Delhi, Dec 10, 2012: Dabur Indi

Bangalore , April 08, 2014 - HCG MS

Mayur Suites Inn is a group of serv

Daily Updates -International

Daily Updates - National

  • 1
  • 2
Prev Next
Omron Blood Pressure Monitor, HEM-7113
Automatic Capsule Filling Machine (PF-150)
Gelusil liquid antacid - Pfizer’s
The Varilux 3.0 range lenses - Essilor
Blossom Kochhar Aroma Magic Anti Pigmentation Serum
 The Property Times